May 17, 2011
Some company executives will be leaving the eye drug firm as it is absorbed by the pharmaceutical giant.
November 30, 2010
Richard Clark will remain chairman of the drug giant when Kenneth Frazier assumes CEO role. Merck operates a vaccine manufacturing plant in Durham.
November 29, 2010
Merck drug also receives support, but reviewers express concern about the overall benefits of the drugs.
November 17, 2010
An experimental Merck drug safely boosted good cholesterol to record highs while dropping bad cholesterol to unprecedented lows in a study that stunned researchers and renewed hopes for an entirely new way of lowering heart risks.
May 4, 2010
The drug giants, which are growing their presence in the Research Triangle region, say first-quarter sales were strong. Wyeth acquisition boosts Pfizer. But Schering-Plough acquisition costs hurt Merck profits.
Updated November 4, 2009
The two pharma giants completed the deal after the markets closed Tuesday, and the new Merck moved up from being the No. 8 drugmaker. creating the No. 2 drug-maker
July 22, 2009
Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.
Updated July 9, 2009
Cervarix could save 'millions of women's lives throughout the world,' GSK exec says. Drug giant is seeking FDA approval in U.S.
Updated June 6, 2009
Drug giant releases results of its own study at diabetes conferencing that it says downplays heart attack risks. WHO, meanwhile, endorses GSK diarrhea drug.
Updated June 3, 2009
Federal regulators on Tuesday cleared British drugmaker GlaxoSmithKline's $3 billion takeover of U.S. dermatology business Stiefel Laboratories Inc.
Updated May 22, 2009
Looking ahead, leaders of 13-county Research Triangle Regional Partnership outline new five-year plan for "Staying on Top." Recruiting pipeline is strong, RTRP’s top exec says. Since 2003, employment grew in all the region’s 13 counties but Warren, which lost 407 jobs.
Updated May 21, 2009
Milken Institute ranks RTP second for innovation as well as research and development. However, lack of 'risk capital' and entrepreneurship helps drag down its overall score.
Updated April 22, 2009
'It is essential that we reconfigure our U.S. business to make sure we have the right resource in the right areas and an overall lower level of infrastructure costs,' Andrew Witty says.
Updated April 17, 2009
As yet unnamed company will based U.S. operations in RTP where GSK has a long history of AIDS research. Venture will be No. 2 in HIV drug market share from launch.
Updated March 18, 2009
North Carolina native to help coordinate research efforts at N.C. Research Institute.
Updated October 17, 2008
Despite an increase of more than 6,000 jobs, the state’s jobless rate has hit its highest level in six years.